Global Bio-chem Technology Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 4.4yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
Global Bio-chem Technology Group's (HKG:809) Earnings Aren't As Good As They Appear
Sep 19
Subdued Growth No Barrier To Global Bio-chem Technology Group Company Limited's (HKG:809) Price
Mar 05Global Bio-chem Technology Group Company Limited's (HKG:809) 40% Price Boost Is Out Of Tune With Revenues
Sep 17CEO
Global Bio-chem Technology Group has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | less than a year | no data | no data | |
| COO & Executive Director | 7.8yrs | HK$715.00k | 0.0056% HK$ 50.5k | |
| Company Secretary & Financial Controller | 6.7yrs | no data | no data | |
| Chief Accountant | 2.1yrs | no data | no data |
4.4yrs
Average Tenure
52yo
Average Age
Experienced Management: 809's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | less than a year | no data | no data | |
| COO & Executive Director | 2.2yrs | HK$715.00k | 0.0056% HK$ 50.5k | |
| Non-Executive Director | 1.3yrs | no data | no data | |
| Independent Non-Executive Director | 1.3yrs | HK$47.00k | no data | |
| Independent Non-Executive Director | 1.3yrs | HK$47.00k | no data | |
| Independent Non-Executive Director | 1.3yrs | HK$31.00k | no data |
1.3yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 809's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 06:48 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Global Bio-chem Technology Group Company Limited is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frank Lai | BOCI Research Ltd. |
| Feiyang Yuan | China International Capital Corporation Limited |
| K. Lau | Citigroup Inc |